MEDICINOVA, INC. Depreciation
MEDICINOVA, INC. (MNOV) reported Depreciation of $14.13 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2017-02-14
- MEDICINOVA, INC. depreciation for fiscal 2016 was $14.13K, a 47.10% decline from fiscal 2015.
- MEDICINOVA, INC. depreciation for fiscal 2015 was $26.70K, a 33.55% decline from fiscal 2014.
- MEDICINOVA, INC. depreciation for fiscal 2014 was $40.19K, a 9.63% increase from fiscal 2013.
- MEDICINOVA, INC. depreciation for fiscal 2013 was $36.66K, a 9.40% increase from fiscal 2012.
| Period end | Depreciation 12 month |
|---|---|
| 2016-12-31 | $14.13K 10-K · filed 2017-02-14 |
| 2015-12-31 | $26.70K 10-K · filed 2017-02-14 |
| 2014-12-31 | $40.19K 10-K · filed 2016-02-25 |
| 2013-12-31 | $36.66K 10-K · filed 2015-03-12 |
| 2012-12-31 | $33.51K 10-K · filed 2014-03-27 |
| 2011-12-31 | $41.87K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |